Dong-A St (170900)

Currency in KRW
48,500
-800(-1.62%)
Closed·
170900 Scorecard
Full Analysis
Net income is expected to grow this year
170900 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
48,20049,550
52 wk Range
40,90080,700
Key Statistics
Bid/Ask
48,450.00 / 48,500.00
Prev. Close
49,300
Open
49,550
Day's Range
48,200-49,550
52 wk Range
40,900-80,700
Volume
22.7K
Average Volume (3m)
19.83K
1-Year Change
-31.5%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
170900 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
70,641
Upside
+45.65%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Dong-A St News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Dong-A St Company Profile

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Dulastin PFS and Leucostim injection/PFS to treat neutropenia in patients receiving myelosuppressive chemotherapy; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin inj./PFS for infertility and anovulation; Growtropin II inj./AQ /cartridge to treat growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Mainta inj. for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel inj. to treat breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone tab. for use in functional dyspepsia treatment; Stillen tab. to treat gastritis; Suganon tab./Sugamet XR tab. for type 2 diabetes mellitus; Terizidone tab to treat active pulmonary and extra-pulmonary tuberculosis; and Zydena tab. for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high-technology medical devices, custom-made products, and sets of artificial cardiac circuits for use in open-heart surgery. Dong-A ST Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.

Employees
1687

Compare 170900 to Peers and Sector

Metrics to compare
170900
Peers
Sector
Relationship
P/E Ratio
−559.7x10.8x−0.5x
PEG Ratio
−6.500.020.00
Price/Book
0.7x1.0x2.6x
Price / LTM Sales
0.6x0.6x3.2x
Upside (Analyst Target)
42.3%29.1%41.7%
Fair Value Upside
Unlock34.1%6.1%Unlock

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 70,641
(+45.65% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -87.58%
Dividend Yield
1.44%
Industry Median 0.93%
Annualised payout
700.00
Paid annually
5-Years Growth
-6.14%
Growth Streak

Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
-- / 1,381.00
Revenue / Forecast
177.40B / 176.84B
EPS Revisions
Last 90 days

170900 Income Statement

People Also Watch

158,900
103140
+0.57%
141,500
141080
-2.41%
10,350
056080
+0.10%
8,650
060280
-1.03%
40,500
083650
0.00%

FAQ

What Stock Exchange Does Dong-A St Trade On?

Dong-A St is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for Dong-A St?

The stock symbol for Dong-A St is "170900."

What Is the Dong-A St Market Cap?

As of today, Dong-A St market cap is 444.42B.

What Is Dong-A St's Earnings Per Share (TTM)?

The Dong-A St EPS (TTM) is -87.58.

When Is the Next Dong-A St Earnings Date?

Dong-A St will release its next earnings report on 11 Nov 2025.

From a Technical Analysis Perspective, Is 170900 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Dong-A St Stock Split?

Dong-A St has split 3 times.

How Many Employees Does Dong-A St Have?

Dong-A St has 1687 employees.

What is the current trading status of Dong-A St (170900)?

As of 26 Jul 2025, Dong-A St (170900) is trading at a price of 48,500.00, with a previous close of 49,300.00. The stock has fluctuated within a day range of 48,200.00 to 49,550.00, while its 52-week range spans from 40,900.00 to 80,700.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.